Tokyo Tape
Sign in
← Sundrug

Quarterly report · Q2

9989.TEDINET S100PMIV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥339.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥648.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥326.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥18.5bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥17.9bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥18.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥34.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥18.2bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥18.5bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥18.3bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥12.7bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥23.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥12.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥12.7bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥12.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥337.1bnat 2022-09-30Cons.Assets
Total assets¥325.8bnat 2022-03-31Cons.Assets
Total assets¥313.5bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥108.0bnat 2022-09-30Cons.Liabilities
Total liabilities¥105.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥229.1bnat 2022-09-30Cons.Net assets
Net assets / equity¥220.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥213.3bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥94.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥89.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥94.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥89.3bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥90.3bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥86.5bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥21.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥31.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥16.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥12.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥20.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.9bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥4.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥8.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥108.812022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥54.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥204.022021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥106.542021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.362021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥108.812022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥204.012021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥106.532021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio68.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio67.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio68.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥24.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥24.7bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-09-30¥143.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-09-30¥143.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-09-30¥220.0bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-09-30¥195.3bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥24.7bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-09-30¥11.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥363.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥339.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥24.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥18.5bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥22.9bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥22.9bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue2021-04-01 → 2021-09-30¥134.1bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue external2021-04-01 → 2021-09-30¥134.1bn
jpcrp040300-q2r_E03226-000Discount Storereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥6m
jpcrp040300-q2r_E03226-000Discount Storereportable segmentsegment profit2021-04-01 → 2021-09-30¥6.1bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue2021-04-01 → 2021-09-30¥215.5bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue external2021-04-01 → 2021-09-30¥192.6bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥22.9bn
jpcrp040300-q2r_E03226-000Drug Storereportable segmentsegment profit2021-04-01 → 2021-09-30¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥349.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥326.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥22.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥17.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Gain on sales of noncurrent assets eiPrior1YTDDuration285000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Penalty income eiPrior1YTDDuration－JPY
Penalty income eiCurrentYTDDuration5000000JPY
State subsidy eiPrior1YTDDuration－JPY
State subsidy eiCurrentYTDDuration8000000JPY
Other eiPrior1YTDDuration7000000JPY
Other eiCurrentYTDDuration2000000JPY
Extraordinary incomePrior1YTDDuration292000000JPY
Extraordinary incomeCurrentYTDDuration17000000JPY
Impairment loss elPrior1YTDDuration87000000JPY
Impairment loss elCurrentYTDDuration160000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration89000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration36000000JPY
Other elPrior1YTDDuration44000000JPY
Other elCurrentYTDDuration75000000JPY
Extraordinary lossPrior1YTDDuration222000000JPY
Extraordinary lossCurrentYTDDuration273000000JPY
Income before income taxesPrior1YTDDuration18310000000JPY
Income before income taxesCurrentYTDDuration18513000000JPY
Income taxesPrior1YTDDuration5855000000JPY
Income taxesCurrentYTDDuration5791000000JPY
Profit lossPrior1YTDDuration12455000000JPY
Profit lossCurrentYTDDuration12722000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY
Profit loss attributable to owners of parentPrior1YTDDuration12455000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration12722000000JPY
Profit lossPrior1YTDDuration12455000000JPY
Profit lossCurrentYTDDuration12722000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-0JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration8000000JPY
Revaluation reserve for land net of tax ociPrior1YTDDuration176000000JPY
Revaluation reserve for land net of tax ociCurrentYTDDuration－JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration10000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration6000000JPY
Other comprehensive incomePrior1YTDDuration187000000JPY
Other comprehensive incomeCurrentYTDDuration15000000JPY
Comprehensive incomePrior1YTDDuration12642000000JPY
Comprehensive incomeCurrentYTDDuration12737000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration12642000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration12737000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration－JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration18310000000JPY
Income before income taxesCurrentYTDDuration18513000000JPY
Depreciation and amortization ope cfPrior1YTDDuration4756000000JPY
Depreciation and amortization ope cfCurrentYTDDuration5435000000JPY
Impairment loss ope cfPrior1YTDDuration87000000JPY
Impairment loss ope cfCurrentYTDDuration160000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass